17 alpha-hydroxyprogesterone caproate has been researched along with testosterone enanthate in 1 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (testosterone enanthate) | Trials (testosterone enanthate) | Recent Studies (post-2010) (testosterone enanthate) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 570 | 143 | 116 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and testosterone enanthate
| Article | Year |
|---|---|
Acceptability of drugs for male fertility regulation: a prospectus and some preliminary data. World Health Organization Task Force on Psychosocial Research in Family Planning.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Clinical Trials as Topic; Contraceptive Agents, Male; Contraceptive Devices, Male; Cyproterone; Cyproterone Acetate; Humans; Hydroxyprogesterones; Libido; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Sexual Behavior; Testosterone; Vasectomy; World Health Organization | 1980 |